#GSK has reported positive clinical results with an #antibodydrugconjugate licensed from China's #HansohPharma in 2023, delivering an early fillip for new chief executive Luke Miels.

pharmaphorum.com/news/data-ba...

Emma Walmsley upholds £40B sales target in her final GSK CEO report Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. | Emma Walmsley and her ...

#GSK #EmmaWalmsley #LukeMiels #Blenrep #Arexvy #Shingrix #multiplemyeloma #PD1inhibitor #Jemperli #rectalcancer #antibodydrugconjugates #ADCs #HansohPharma #FDAapproval #longactingbiologic #depemokima #chronicrhinosinusitis #biologics #vaccines #shinglesvaccine #RSVvaccine
zurl.co/iumHW

Merck's $2 Billion Licensing Deal with Hansoh Pharma Targets Oral GLP-1 Obesity Market Merck has entered the competitive oral GLP-1 obesity treatment arena through a global licensing partnership with Chinese biotech Hansoh Pharma, marking a significant move in the race to develop innova...

www.linkedin.com/pulse/mercks...

Merck's $2 Billion Licensing Deal with Hansoh Pharma Targets Oral GLP-1 Obesity Market

kstrategyand.com/pharma-news

#Merck #HansohPharma #ObesityTreatment #GLP1 #DigitalHealth #HealthInnovation #Humanteconomy #Humantec #KStrategyand